2551 - 2575 of 8587 Results
Title
Year
- Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up2021OPENTitle: Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐upJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2257Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2257Citation Count: 15
- Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity study2021OPENTitle: Characterizing resting‐state networks in Parkinson’s disease: A multi‐aspect functional connectivity studyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2101Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2101Citation Count: 13
-
OPENTitle: Psychometric properties of the Beck Depression Inventory‐II in progressive supranuclear palsyJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2344Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2344Citation Count: 13
- Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contrary2021OPENTitle: Impaired awareness: Why people with multiple sclerosis continue using cannabis despite evidence to the contraryJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/brb3.2220Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2220Citation Count: 7
-
OPENTitle: Olfactory impairment in Wilson’s diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/brb3.2022Citation Count: 14
-
OPENTitle: Comparison between four published definitions of hyposmia in Parkinson's diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2258Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2258Citation Count: 7
- Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiency2021OPENTitle: Modelling item scores of Unified Parkinson's Disease Rating Scale Part III for greater trial efficiencyJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 87Issue #: 9Start Page: 3608End Page: 3618Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bcp.14777Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.14777Citation Count: 15
-
OPENTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12526Citation Count: 30
- A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 Mutation2021OPENTitle: A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson’s Disease in Participants With Leucine‐Rich Repeat Kinase 2 MutationJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 2Start Page: 508End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.2277Citation Count: 13
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy2021OPENTitle: Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant EpilepsyJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 5Start Page: 1368End Page: 1380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cpt.2408Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408Citation Count: 31
- The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging study2021RESTRICTEDTitle: The effect of polygenic risk on white matter microstructural degeneration in Parkinson's disease: A longitudinal Diffusion Tensor Imaging studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 4Start Page: 1000End Page: 1010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.15201Citation Count: 4
-
OPENTitle: Worldwide barriers to genetic testing for movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 6Start Page: 1901End Page: 1909Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.14826Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14826Citation Count: 35
- Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s disease2021OPENTitle: Effects of exergaming on hippocampal volume and brain‐derived neurotrophic factor levels in Parkinson’s diseaseJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: 2Start Page: 441End Page: 449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/ene.15165Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15165Citation Count: 32
- Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort study2021OPENTitle: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 10Start Page: 3348End Page: 3359Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14803Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14803Citation Count: 169
-
OPENTitle: Germline Saturation Mutagenesis Induces Skeletal Phenotypes in MiceJournal Name: Journal of Bone and Mineral ResearchPublisher: Oxford University Press (OUP)Vol: 36Issue #: 8Start Page: 1548End Page: 1565Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jbmr.4323Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8862308Citation Count: 8
- Plasma membrane calcium ATPase downregulation in dopaminergic neurons alters cellular physiology and motor behaviour in Drosophila melanogaster2021RESTRICTEDTitle: Plasma membrane calcium ATPase downregulation in dopaminergic neurons alters cellular physiology and motor behaviour in Drosophila melanogasterJournal Name: European Journal of NeurosciencePublisher: WileyVol: 54Issue #: 6Start Page: 5915End Page: 5931Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.15401Citation Count: 5
- Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurology2021OPENTitle: Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurologyJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 30Issue #: 4Start Page: 974End Page: 983Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jgc4.1470Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jgc4.1470Citation Count: 24
- Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease2021RESTRICTEDTitle: Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 158Issue #: 4Start Page: 833End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.15442Citation Count: 9
-
RESTRICTEDTitle: Deep learning‐based scheme to diagnose Parkinson's diseaseJournal Name: Expert SystemsPublisher: WileyVol: 39Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/exsy.12739Citation Count: 46
-
OPENTitle: Differentiation of multiple system atrophy subtypes by gray matter atrophyJournal Name: Journal of NeuroimagingPublisher: WileyVol: 32Issue #: 1Start Page: 80End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jon.12927Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jon.12927Citation Count: 8
- fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer’s disease using an automated quantitative analysis workflow2020OPENTitle: fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer’s disease using an automated quantitative analysis workflowJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 4Start Page: 1270End Page: 1283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15283Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15283Citation Count: 6
- Alpha‐Synuclein oligomerization and aggregation: All models are useful but only if we know what they model2020OPENTitle: Alpha‐Synuclein oligomerization and aggregation: All models are useful but only if we know what they modelJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 4Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15275Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15275Citation Count: 7
- Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synuclein2021OPENTitle: Sigma‐2 receptor antagonists rescue neuronal dysfunction induced by Parkinson’s patient brain‐derived α‐synucleinJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 99Issue #: 4Start Page: 1161End Page: 1176Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jnr.24782Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/jnr.24782Citation Count: 32
- Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease2021OPENTitle: Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 302End Page: 314Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28849Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28849Citation Count: 25
-
OPENTitle: The contribution of behavioral features to caregiver burden in FTLD spectrum disordersJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 9Start Page: 1635End Page: 1649Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.12494Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9160199Citation Count: 22